Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Growth Factors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT00364507
What this trial is testing

Serum Levels of Insulin- Like Growth Factor and Fertility

Who this might be right for
Fertility
Hadassah Medical Organization 60
Not applicableStudy completedNCT04531800
What this trial is testing

Surgical Management of Medication Related Osteonecrosis of the Jaws With Concentrated Growth Factor

Who this might be right for
Healing Surgical WoundsInfection
Ege University 28
Testing effectiveness (Phase 2)Ended earlyNCT01066871
What this trial is testing

Sprifermin (AS902330) in Cartilage Injury Repair (CIR)

Who this might be right for
Isolated Cartilage Injury of the Knee
Merck KGaA, Darmstadt, Germany 74
Not applicableAvailableNCT07601399
What this trial is testing

An EAP Treatment Protocol of Zipalertinib

Who this might be right for
Non-Small Cell Lung Cancer
Taiho Oncology, Inc.
Testing effectiveness (Phase 2)Study completedNCT01153984
What this trial is testing

Assess Biomarkers Impact on Participants Response to Erlotinib Treatment for First-line Non-Small Cell Lung Cancer With Endothelial Growth Factor Receptor (EGFR) Activating Mutations

Who this might be right for
Carcinoma，Non-Small-Cell Lung
Hoffmann-La Roche 23
Testing effectiveness (Phase 2)WithdrawnNCT00908219
What this trial is testing

Bevacizumab to Prevent Malignant Ascites

Who this might be right for
Malignant Ascites
Baylor College of Medicine
Large-scale testing (Phase 3)Study completedNCT00346437
What this trial is testing

Efficacy and Safety of Intracoronary Ad5FGF-4 in Patients With Stable Angina (AGENT-3)

Who this might be right for
Angina Pectoris
Cardium Therapeutics 416
Not applicableStudy completedNCT07375407
What this trial is testing

Aerobic Exercise vs Physiological Ischemic Training in Stage 2 Hypertension

Who this might be right for
Primary Hypertension, Grade 2
Universitas Padjadjaran 60
Testing effectiveness (Phase 2)Study completedNCT01310036
What this trial is testing

Tarceva (Erlotinib) as First Line Therapy in Participants With Non-Small Cell Lung Cancer Harbouring Epidermal Growth Factor Receptor (EGFR) Mutations

Who this might be right for
Non-Squamous Non-Small Cell Lung Cancer
Hoffmann-La Roche 208
Testing effectiveness (Phase 2)Study completedNCT00117299
What this trial is testing

PTK787/ZK222584 in the Treatment of Metastatic Gastrointestinal Stromal Tumors Resistant to Imatinib

Who this might be right for
Sarcoma
University of Helsinki 45
Not applicableStudy completedNCT00446381
What this trial is testing

Effect of Macugen(Pegaptanib)on Surgical Outcomes and VEGF Levels in Diabetic Patients With PDR (Diabetic Retinopathy or CSDME (Macular Edema)

Who this might be right for
Proliferative Diabetic RetinopathyDiabetic Macular Edema
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 28
Not applicableUnknownNCT01627119
What this trial is testing

The Functional and Clinicopathological Roles and Therapeutic Implication of Connective Tissue Growth Factor in Peritoneal Metastasis of Gastric Cancer

Who this might be right for
Gastric Cancer
National Taiwan University Hospital 120
Early research (Phase 1)Study completedNCT04818632
What this trial is testing

AZD9833 China PK Study

Who this might be right for
ER+, HER2-, Metastatic Breast Cancer
AstraZeneca 28
Not applicableStudy completedNCT07086196
What this trial is testing

Real-World Outcomes of Ribociclib in First-Line Treatment for Metastatic HR+/HER2- Breast Cancer

Who this might be right for
Metastatic HR+/HER2- Breast Cancer
Novartis Pharmaceuticals 350
Not applicableActive Not RecruitingNCT06846073
What this trial is testing

Early Combined Use of Dexamethasone Intravitreal Implant and Anti-VEGF in the Treatment of DME.

Who this might be right for
Diabetic Macular Edema (DME)
Second Affiliated Hospital, Zhejiang University, School of Medicine 70
Early research (Phase 1)Active Not RecruitingNCT05870579
What this trial is testing

[177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer

Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 28
Not applicableStudy completedNCT02321046
What this trial is testing

An epidemiOlogy Study to deteRmine the Prevalence of EGFR (Epidermal Growth Factor Receptor) muTations in RUSsian Patients With Advanced NSCLC (Non-Small Cell Lung Cancer).

Who this might be right for
Non-Small Cell Lung Cancer
AstraZeneca 26
Not applicableActive Not RecruitingNCT06494241
What this trial is testing

Small/Middle Tier Cities and County Lung Cancer Quality Improvement Project (QIP) Study

Who this might be right for
Carcinoma, Non-Small-Cell LungLung NeoplasmsRespiratory Tract Neoplasms+7 more
AstraZeneca 1,000
Testing effectiveness (Phase 2)Looking for participantsNCT07329322
What this trial is testing

Phase II Study of Sacituzumab Tirumotecan in Combination With Osimertinib for Neoadjuvant Treatment in Patients With Resectable Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 30
Not applicableStudy completedNCT05982197
What this trial is testing

Curcumin Gel On Radiation Induced Oral Mucositis

Who this might be right for
Radiation-Induced MucositisHead and Neck Cancer
University of Baghdad 40
Next Page